Increased distractor vulnerability but preserved vigilance in patients with schizophrenia: Evidence from a translational Sustained Attention Task

Schizophrenia Research

Volumn 144, Issue 1-3, 2013, Pages 136-141

  Demeter, Elise ^a,b   Guthrie, Sally K ^a,b   Taylor, Stephan F ^b   Sarter, Martin ^a   Lustig, Cindy ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Attentional control; CNTRICS; Distraction; Schizophrenia; Sustained attention

Indexed keywords

ADULT; ALERTNESS; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR CONTROL; CHILD; COGNITION; CONTROLLED STUDY; DISTRACTIBILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; SCHOOL CHILD; SCORING SYSTEM; SUSTAINED ATTENTION TASK; TASK PERFORMANCE;

ADULT; ATTENTION; CHILD; CHILD DEVELOPMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84873525723     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.01.003     Document Type: Article

References (46)

1. Andreasen N.C. The scale for the assessment of negative symptoms 1983, The University of Iowa, Iowa City, Iowa.
2. Asarnow R.F., MacCrimmon D.J. Residual performance deficit in clinically remitted schizophrenics: a marker of schizophrenia?. J. Abnorm. Psychol. 1978, 87(6):597-608.
3. Asato M.R., Terwilliger R., Woo J., Luna B. White matter development in adolescence: a DTI study. Cereb. Cortex 2010, 20(9):2122-2131.
4. Barch D.M., Ceaser A. Cognition in schizophrenia: core psychological and neural mechanisms. Trends Cogn. Sci. 2012, 16(1):27-34.
5. Berry, A.S., Demeter, E., Askren, M.K., Sarter, M., Lustig, C., personal communication. Distraction versus detection: evidence for differentially lateralized frontoparietal control processes from the distractor condition sustained attention task.
6. Betts J., Mckay J., Maruff P., et al. The development of sustained attention in children: the effect of age and task load. Child Neuropsychol. 2006, 12(3):205-221.
7. Bhojraj T.S., Francis A.N., Montrose D.M., Keshavan M.S. Grey matter and cognitive deficits in young relatives of schizophrenia patients. NeuroImage 2011, 54:S287-S292.
8. Butler P.D., Zemon V., Schechter I., Saperstein A.M., Hoptman M.J., Lim K.O., Revheim N., Silipo G., Javitt D.C. Early-stage visual processing and cortical amplification deficits in schizophrenia. Arch. Gen. Psychiatry 2005, 62(5):495-504.
9. Carter C.S., Barch D.M. Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative. Schizophr. Bull. 2007, 33(5):1131-1137.
10. Demeter E., Sarter M., Lustig C. Rats and humans paying attention: cross-species task development for translational research. Neuropsychology 2008, 22(6):787-799.
11. Demeter E., Hernandez-Garcia L., Sarter M., Lustig C. Challenges to attention: a continuous arterial spin labeling (ASL) study of the effects of distraction on sustained attention. NeuroImage 2011, 54(2):1518-1529.
12. Egeland J., Rund B.R., Sundet K., Landro N.I., Asbjornsen A., Lund A., Roness A., Stordal K.I., Hugdahl K. Attention profile in schizophrenia compared with depression: differential effects of processing speed, selective attention and vigilance. Acta Psychiatr. Scand. 2003, 108(4):276-284.
13. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W., Davies M., Borus J., Howes M.J., Kane J., Pope H.G., Rounsaville B. The structured clinical interview for DSM-III-R personality disorders (SCID-II). Part II: multi-site test-retest reliability study. J. Personal. Disord. 1995, 9(2):92-104.
14. Frey P.W., Colliver J.A. Sensitivity and response measures for discrimination learning. Learn. Motiv. 1973, 4:327-342.
15. Gold J.M., Fuller R.L., Robinson B.M., Braun E.L., Luck S.J. Impaired top-down control of visual search in schizophrenia. Schizophr. Res. 2007, 94(1-3):148-155.
16. Green M.F., Kern R.S., Braff D.L., Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr. Bull. 2000, 26(1):119-136.
17. Hahn B., Robinson B.M., Kaiser S.T., Matveeva T.M., Harvey A.N., Luck S.J., Gold J.M. Kraepelin and Bleuler had it right: people with schizophrenia have deficits sustaining attention over time. J. Abnorm. Psychol. 2012, 121(3):641-648.
18. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
19. Heinrichs R.W., Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998, 12(3):426-445.
20. Hill S.K., Bishop J.R., Palumbo D., Sweeney J.A. Effect of second-generation antipsychotics on cognition: current issues and future challenges. Expert. Rev. Neurother. 2010, 10(1):43-57.
21. Hilti C.C., Hilti L.M., Heinemann D., Robbins T., Seifritz E., Cattapan-Ludewig K. Impaired performance on the Rapid Visual Information Processing task (RVIP) could be an endophenotype of schizophrenia. Psychiatry Res. 2010, 177(1-2):60-64.
22. Holmes A.J., MacDonald A., Carter C.S., Barch D.M., Andrew Stenger V., Cohen J.D. Prefrontal functioning during context processing in schizophrenia and major depression: an event-related fMRI study. Schizophr. Res. 2005, 76(2-3):199-206.
23. Kozak R., Martinez V., Young D., Brown H., Bruno J.P., Sarter M. Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats. Neuropsychopharmacology 2007, 32(10):2074-2086.
24. Luck S.J., Gold J.M. The construct of attention in schizophrenia. Biol. Psychiatry 2008, 64(1):34-39.
25. Luck S.J., Ford J.M., Sarter M., Lustig C. CNTRICS final biomarker selection: control of attention. Schizophr. Bull. 2012, 38(1):53-61.
26. Lustig C., Kozak R., Sarter M., Young J.W., Robbins T.W. CNTRICS final animal model task selection: control of attention. Neurosci. Biobehav. Rev. 2012.
27. Mass R., Wolf K., Wagner M., Haasen C. Differential sustained attention/vigilance changes over time in schizophrenics and controls during a degraded stimulus continuous performance test. Eur. Arch. Psychiatry Clin. Neurosci. 2000, 250(1):24-30.
28. McGaughy J., Sarter M. Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology (Berl) 1995, 117(3):340-357.
29. McKay K.E., Halperin J.M., Schwartz S.T., Sharma V. Developmental analysis of 3 aspects of information-processing - sustained attention, selective attention, and response organization. Dev. Neuropsychol. 1994, 10(2):121-132.
30. Minzenberg M.J., Laird A.R., Thelen S., Carter C.S., Glahn D.C. Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch. Gen. Psychiatry 2009, 66(8):811-822.
31. Nuechterlein K.H., Snyder K.S., Mintz J. Paths to relapse: possible transactional processes connecting patient illness onset, expressed emotion, and psychotic relapse. Br. J. Psychiatry 1992, (18):88-96. (Suppl.).
32. Nuechterlein K.H., Barch D.M., Gold J.M., Goldberg T.E., Green M.F., Heaton R.K. Identification of separable cognitive factors in schizophrenia. Schizophr. Res. 2004, 72(1):29-39.
33. Nuechterlein K.H., Luck S.J., Lustig C., Sarter M. CNTRICS final task selection: control of attention. Schizophr. Bull. 2009, 35(1):182-196.
34. Overall J.E., Gorham D.R. Brief psychiatric rating scale. Psychol. Rep. 1962, 10:799-812.
35. Robbins T.W. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 2002, 163(3-4):362-380.
36. Sarter M. Preclinical research into cognition enhancers. Trends Pharmacol. Sci. 2006, 27(11):602-608.
37. Sarter M., McGaughy J. Assessment of sustained and divided attention in rats: aspects of validity; [comment]. Psychopharmacology (Berl) 1998, 138(3-4):260-262. (discussion 263-265).
38. Sarter M., Martinez V., Kozak R. A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia. Psychopharmacology (Berl) 2009, 202(1-3):237-258.
39. Sarter M., Lustig C., Taylor S.F. Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatments. Neuropharmacology 2012, 62(3):1544-1553.
40. St Peters M., Cherian A.K., Bradshaw M., Sarter M. Sustained attention in mice: expanding the translational utility of the SAT by incorporating the Michigan Controlled Access Response Port (MICARP). Behav. Brain Res. 2011, 225(2):574-583.
41. St Peters M., Demeter E., Lustig C., Bruno J.P., Sarter M. Enhanced control of attention by stimulating mesolimbic-corticopetal cholinergic circuitry. J. Neurosci. 2011, 31(26):9760-9771.
42. Swets J., Tanner W.P., Birdsall T.G. Decision processes in perception. Psychol. Rev. 1961, 68:301-340.
43. Tandon R., Nasrallah H.A., Keshavan M.S. Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future. Schizophr. Res. 2010, 122(1-3):1-23.
44. Theeuwes J. Stimulus-driven capture and attentional set: selective search for color and visual abrupt onsets. J. Exp. Psychol. Hum. Percept. Perform. 1994, 20(4):799-806.
45. Wohlberg G.W., Kornetsky C. Sustained attention in remitted schizophrenics. Arch. Gen. Psychiatry 1973, 28(4):533-537.
46. Young J.W., Light G.A., Marston H.M., Sharp R., Geyer M.A. The 5-choice continuous performance test: evidence for a translational test of vigilance for mice. PLoS One 2009, 4(1):e4227.